Yuping Qian

机构：Second Military Medical University, Yale Cancer Center, Yale University, Changhai Hospital · ORCID：0000-0002-9352-0157

发表论文 13 篇 · 总被引 131 次 · h-index 6

代表论文

• Neoleukin-2/15-armored CAR-NK cells sustain superior therapeutic efficacy in solid tumors via c-Myc/NRF1 activation (2025 · Signal Transduction and Targeted Therapy · 被引 46)
• A first-in-class selective inhibitor of ERK1/2 and ERK5 overcomes drug resistance with a single-molecule strategy (2025 · Signal Transduction and Targeted Therapy · 被引 19)
• Intratumor heterogeneity and clonal evolution revealed in castration-resistant prostate cancer by longitudinal genomic analysis (2021 · Translational Oncology · 被引 18)
• Proliferation of Highly Cytotoxic Human Natural Killer Cells by OX40L Armed NK-92 With Secretory Neoleukin-2/15 for Cancer Immunotherapy (2021 · Frontiers in Oncology · 被引 13)
• A drug delivery platform using engineered MUC1‐targeting exosomes enhances chemosensitivity and immunogenic cell death in pancreatic ductal adenocarcinoma (2024 · SmartMat · 被引 10)
• Intratumoral IL12 mRNA administration activates innate and adaptive pathways in checkpoint inhibitor-resistant tumors resulting in complete responses (2025 · Cancer Immunology Immunotherapy · 被引 8)